Don Ariyakumar M.S , MBA
About Don Ariyakumar M.S , MBA
Don Ariyakumar is a Strategic Product Marketing Manager at Hamamatsu Corporation, where he has worked since 2022. He has a diverse background in healthcare marketing and business development, with previous roles at PATH, Philips, and the State of Nevada Health Division.
Current Role at Hamamatsu Corporation
Don Ariyakumar M.S, MBA serves as the Strategic Product Marketing Manager at Hamamatsu Corporation since 2022. In this role, he focuses on developing and implementing marketing strategies that align with the company's objectives. His responsibilities include overseeing product marketing initiatives and ensuring effective communication between technology and customer needs.
Previous Experience at PATH
Prior to his current position, Don worked at PATH as a Global Product Manager (Commercialization Officer) from 2018 to 2019. During his tenure, he was involved in product management and commercialization efforts, contributing to the development of healthcare solutions in Seattle, Washington, and Portland, Oregon.
Educational Background
Don holds an Executive MBA from IE Business School. He also earned a Master of Science in Biology and a Bachelor of Science in Biology from New Mexico State University. Additionally, he studied Change Markers in Global Food and Agribusiness at University College Dublin, enhancing his knowledge in the intersection of business and science.
Expertise in Healthcare Marketing and Business Development
Don possesses expertise in healthcare marketing and business development, with a focus on bridging technology and interpersonal relationships. His professional experience includes roles in various organizations, where he emphasized the importance of innovative products and strong connections in advancing industries.
Career History and Roles
Don's career includes significant roles such as Product Manager for the Americas at Hamamatsu Corporation from 2019 to 2022, Director of the Nevada Central Cancer Registry from 2012 to 2014, and Laboratory Manager in Ultrastructure Pathology at the University of Minnesota from 2007 to 2012. He also worked as a Business Development Manager in Computational Pathology at Philips from 2014 to 2018.